Send to

Choose Destination
Vet Hum Toxicol. 2002 Feb;44(1):19-21.

Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.

Author information

Emergency Department, Taichung Veterans General Hospital, Taiwan.


Methylene blue is utilized as the main treatment of methemoglobinemia conventionally, but it may be ineffective in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. We report a G6PD-deficient patient who suffered from aniline-induced methemoglobinemia with initial good response Heinz body but hemolytic anemia appeared later 3 d after methylene blue therapy. G6PD deficiency was identified. He recovered uneventfully with hydration, packed blood transfusion and adjuvant luvela-N(dl-alpha-tocopheryl nicotinate) medication. Caution should be taken in using methylene blue as antidote of acute methemoglobinemia, especially when a history of G6PD deficiency is obscure.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center